Teratoma Combined with Struma Ovarii and Sarcomatoid Carcinoma: a Case Report and Review of the Literature

Overview

Journal BMC Womens Health

Publisher Biomed Central

Specialty Gynecology & Obstetrics

Date 2024 Sep 14

PMID 39277716

Authors

Haojie Qin

Dan Chen

Shan Jin

Jia Liu

Bo Gao

Yongpeng Wang

Affiliations

Soon will be listed here.

Abstract

This is a rare case of struma ovarii combined with sarcomatoid carcinoma. Because struma ovarii and ovarian sarcomatoid carcinoma have an extremely low incidence, this may be the first case of a combined occurrence of both. Therefore, this report describes its clinical manifestations, diagnosis, and treatment, analyzes the pathogenesis, and summarizes the previous literature in the hope that it can be helpful to other tumor-related medical personnel and provide material support for the formation of guidelines for this disease.

References

Aoki M, Takaya H, Otani T, Nakai H, Murakami K, Matsumura N . Ovarian teratoid carcinosarcoma with a mutation: a case report and review of the literature. Int Cancer Conf J. 2022; 11(4):231-237. PMC: 9522960. DOI: 10.1007/s13691-022-00571-w. View

McCluggage W, Singh N, Gilks C . Key changes to the World Health Organization (WHO) classification of female genital tumours introduced in the 5th edition (2020). Histopathology. 2022; 80(5):762-778. DOI: 10.1111/his.14609. View

Strachowski L, Jha P, Phillips C, Blanchette Porter M, Froyman W, Glanc P . O-RADS US v2022: An Update from the American College of Radiology's Ovarian-Adnexal Reporting and Data System US Committee. Radiology. 2023; 308(3):e230685. DOI: 10.1148/radiol.230685. View

Egan C, Stefanova D, Thiesmeyer J, Lee Y, Greenberg J, Beninato T . Proposed Risk Stratification and Patterns of Radioactive Iodine Therapy in Malignant Struma Ovarii. Thyroid. 2022; 32(9):1101-1108. DOI: 10.1089/thy.2022.0145. View

Mitrou S, Manek S, Kehoe S . Cystic struma ovarii presenting as pseudo-Meigs' syndrome with elevated CA125 levels. A case report and review of the literature. Int J Gynecol Cancer. 2008; 18(2):372-5. DOI: 10.1111/j.1525-1438.2007.00998.x. View

Ismail A, Choi S, Boussios S . Frontiers of Ovarian Carcinosarcoma. Curr Treat Options Oncol. 2023; 24(12):1667-1682. PMC: 10781844. DOI: 10.1007/s11864-023-01138-4. View

Dardik R, Dardik M, Westra W, Montz F . Malignant struma ovarii: two case reports and a review of the literature. Gynecol Oncol. 1999; 73(3):447-51. DOI: 10.1006/gyno.1999.5355. View

Medic F, Miletic A, Jakovcevic A, Habek D . Papillary thyroid carcinoma within a mature cystic ovarian teratoma. Wien Med Wochenschr. 2023; 173(9-10):245-247. DOI: 10.1007/s10354-023-01016-6. View

Gama A, Xu H, Yang X, Choy B . Chromophobe Renal Cell Carcinoma with Sarcomatoid Differentiation: Clinicopathologic Correlation and Molecular Findings. Int J Surg Pathol. 2023; 32(1):11-16. DOI: 10.1177/10668969231167527. View

10.

Gadducci A, Guerrieri M, Cosio S . Squamous cell carcinoma arising from mature cystic teratoma of the ovary: A challenging question for gynecologic oncologists. Crit Rev Oncol Hematol. 2019; 133:92-98. DOI: 10.1016/j.critrevonc.2018.10.005. View

11.

Tondi Resta I, Sande C, LiVolsi V . Neoplasms in Struma Ovarii: A Review. Endocr Pathol. 2023; 34(4):455-460. DOI: 10.1007/s12022-023-09789-7. View

12.

Saba L, Guerriero S, Sulcis R, Virgilio B, Melis G, Mallarini G . Mature and immature ovarian teratomas: CT, US and MR imaging characteristics. Eur J Radiol. 2008; 72(3):454-63. DOI: 10.1016/j.ejrad.2008.07.044. View

13.

Armstrong D, Alvarez R, Backes F, Bakkum-Gamez J, Barroilhet L, Behbakht K . NCCN Guidelines® Insights: Ovarian Cancer, Version 3.2022. J Natl Compr Canc Netw. 2022; 20(9):972-980. DOI: 10.6004/jnccn.2022.0047. View

14.

Haight P, Savage J, Bixel K . The poor prognosis of sarcomatoid carcinoma arising from low grade serous ovarian cancer: A case report and review of the literature. Gynecol Oncol Rep. 2021; 36:100735. PMC: 7933262. DOI: 10.1016/j.gore.2021.100735. View

15.

Dujardin M, Sekhri P, Turnbull L . Struma ovarii: role of imaging?. Insights Imaging. 2013; 5(1):41-51. PMC: 3948908. DOI: 10.1007/s13244-013-0303-3. View

16.

Singh P, Lath N, Shekhar S, Goyal M, Gothwal M, Yadav G . Struma Ovarii: A Report of Three Cases and Literature Review. J Midlife Health. 2019; 9(4):225-229. PMC: 6332726. DOI: 10.4103/jmh.JMH_53_18. View

17.

Yang B, Zhong L, Peng L, Huang T, Zhu D, Lu Y . Malignant Struma Ovarii (Papillary Carcinoma) with Hyperthyroidism: A Case Report and Literature Review. Case Rep Oncol. 2023; 16(1):385-390. PMC: 10294126. DOI: 10.1159/000530066. View

18.

Saleh M, Bhosale P, Menias C, Ramalingam P, Jensen C, Iyer R . Ovarian teratomas: clinical features, imaging findings and management. Abdom Radiol (NY). 2021; 46(6):2293-2307. DOI: 10.1007/s00261-020-02873-0. View

19.

Boussios S, Karathanasi A, Zakynthinakis-Kyriakou N, Tsiouris A, Chatziantoniou A, Kanellos F . Ovarian carcinosarcoma: Current developments and future perspectives. Crit Rev Oncol Hematol. 2019; 134:46-55. DOI: 10.1016/j.critrevonc.2018.12.006. View

20.

Timmerman D, Planchamp F, Bourne T, Landolfo C, du Bois A, Chiva L . ESGO/ISUOG/IOTA/ESGE Consensus Statement on pre-operative diagnosis of ovarian tumors. Int J Gynecol Cancer. 2021; 31(7):961-982. PMC: 8273689. DOI: 10.1136/ijgc-2021-002565. View